Advertisement

Strokes are possible complications of cannabinoids use

  • Valérie Wolff
    Correspondence
    Corresponding author at: Stroke Unit, Strasbourg University Hospital, 1, avenue Molière, 67098 Strasbourg, France.
    Affiliations
    Stroke Unit, Strasbourg University Hospital, 1, avenue Molière, 67098 Strasbourg, France

    EA3072, Federation of Translational Medicine of Strasbourg, University of Strasbourg, Strasbourg, France
    Search for articles by this author
  • Emilie Jouanjus
    Affiliations
    Pharmacoepidemiology Team, UMR1027-University of Toulouse, Toulouse, France

    CEIP-Addictovigilance, Department of Medical and Clinical Pharmacology, Toulouse University Hospital, Toulouse, France
    Search for articles by this author
Published:February 24, 2017DOI:https://doi.org/10.1016/j.yebeh.2017.01.031

      Highlights

      • Ninety-eight patients were described as having cannabinoids-related strokes.
      • There is a temporal relationship between cannabinoids and the occurrence of stroke.
      • Reversible vasoconstriction may be a mechanism of stroke in cannabinoids users.
      • Researches are needed to assess the pathophysiology of cannabinoids-related strokes.

      Abstract

      It is critically important to identify all factors that may play a role in the recent increase of the incidence of stroke among the young population. Considering the worldwide use of cannabinoids (cannabis and synthetic cannabinoids), the recent legalization of their consumption in some countries, and their supposed involvement in cardiovascular events, we evaluated their role in the occurrence of neurovascular complications among the young.
      Ninety-eight patients were described in the literature as having a cannabinoids-related stroke (85 after cannabis use and 13 after synthetic cannabinoids). The distribution by type of stroke was as follows: 4 patients with an undetermined type of stroke, 85 with an ischemic stroke and/or a transient ischemic attack, and 9 with a hemorrhagic stroke. The mean age of patients was 32.3 ± 11.8 years (range 15–63), and the majority of them were male with a sex ratio of 3.7:1. Cannabis was often smoked with tobacco in 66% of cases. Most of the patients with cannabinoids-related strokes were chronic cannabis users in 81% of cases, and for 18% of them, there was a recent increase of the amount of cannabis consumption during the days before the occurrence of stroke. Even if the prognosis of stroke was globally favorable in 46% of cases, with no or few sequelae, 5 patients died after the neurovascular event.
      One striking element reported in the majority of the reports was a temporal relationship between cannabinoids use, whether natural or synthetic, and the occurrence of stroke. However, a temporal correlation does not mean causation, and other factors may be involved. Cannabis may be considered as a risk factor of stroke until research shows evidence of an underlying mechanism that, alone or in association with others, contributes to the development of stroke. As of today, reversible cerebral vasoconstriction triggered by cannabinoids use may be a convincing mechanism of stroke in 27% of cases. Indeed, despite the widespread use of cannabinoids, the low frequency of neurovascular complications after their use may be due to a genetic predisposition to their neurovascular toxicity in some individuals. Further studies should focus on this point. More importantly however, this low frequency may be underestimated because the drug consumption may not be systematically researched, neither by questioning nor by laboratory screening. Besides this vascular role of cannabinoids in the occurrence of stroke, a cellular effect of cannabis on brain mitochondria was recently suggested in an experimental study. One of the mechanisms involved in young cannabis users with stroke may be the generation of reactive oxygen species leading to an oxidative stress, which is a known mechanism in stroke in humans. It is useful to inform the young population about the real potential risk of using cannabinoids.
      We suggest to systematically ask all young adults with stroke about their drug consumption including cannabinoids, to screen urine for cannabis or to include a specific diagnostic test to detect synthetic cannabinoids, and to obtain non-invasive intracranial arterial investigations (i.e. CT-angiography or cerebral MRA) in order to search for cerebral vasoconstriction. However, several questions remained unresolved and further research is still needed to assess the pathophysiological mechanisms involved in young cannabinoids users with stroke. This article is part of a Special Issue entitled “Cannabinoids and Epilepsy”.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Epilepsy & Behavior
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Degenhardt L.
        • Hall W.
        Extent of illicit drug use and dependence, and their contribution to the global burden of disease.
        Lancet. 2012; 379: 55-70
      1. United Nations Office on drugs and crime.
        in: World drug report 2013. UN, NewYork (NY)2013
        • Seely K.A.
        • Lapoint J.
        • Moran J.H.
        • Fattore L.
        Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids.
        Prog Neuro-Psychopharmacol Biol Psychiatry. 2012; 39: 234-243
      2. European Monitoring Centre for Drug and Drug Addiction (EMCDDA).
        in: European drug report 2016: trends and developments [internet]. 2016 ([cited 2016 Sep 1. Available from: http://www.emcdda.europa.eu/system/files/publications/2637/TDAT16001ENN.pdf])
        • Ghosh T.
        • Van Dyke M.
        • Maffey A.
        • Whitley E.
        • Gillim-Ross L.
        • Wolk L.
        The public health framework of legalized marijuana in Colorado.
        Am J Public Health. 2016; 106: 21-27
        • Wilkinson S.T.
        • Yarnell S.
        • Radhakrishnan R.
        • Ball S.A.
        • D'Souza D.C.
        Marijuana legalization: impact on physicians and public health.
        Annu Rev Med. 2016; 67: 453-466
        • Wolff V.
        • Armspach J.P.
        • Lauer V.
        • Rouyer O.
        • Bataillard M.
        • Marescaux C.
        • et al.
        Cannabis-related stroke: myth or reality?.
        Stroke. 2013; 44: 558-563
        • Jouanjus E.
        • Raymond V.
        • Lapeyre-Mestre M.
        • Wolff V.
        What is the current knowledge about the cardiovascular risk for users of cannabis-based products? A systematic review.
        Curr Atheroscler Rep. 2017; ([In press])
        • Westover A.N.
        • Mc Bride S.
        • Haley R.W.
        Stroke in young adults who abuse amphetamines or cocaine: population-based study of hospitalized patients.
        Arch Gen Psychiatry. 2007; 64: 495-502
        • Jouanjus E.
        • Lapeyre-Mestre M.
        • Micallef J.
        French Association of the Regional Abuse and Dependence Monitoring Centres (CEIP-A) Working Group on Cannabis Complications*. Cannabis use: signal of increasing risk of serious cardiovascular disorders.
        J Am Heart Assoc. 2014; 3e000638
        • Tournebize J.
        • Gibaja V.
        • Kahn J.-P.
        Acute effects of synthetic cannabinoids: update 2015.
        Subst Abuse. Aug 11 2016; 0 ([Epub ahead of print])
        • World Health Organization. WHO
        The health and social effects of nonmedical cannabis use [internet].
        2016 ([Geneva, Switzerland; p. 62. Available from: http://www.who.int/substance_abuse/publications/cannabis_report/en/])
      3. Haute Autorité de Santé. Accident vasculaire cérébral: prise en charge précoce. (alerte, phase préhospitalière, phase hospitalière initiale, indications de la thrombolyse).
        in: Recommandations de bonnes pratiques. HAS; Mai, Saint Denis La Plaine2009
        • Chatzikonstantinou A.
        • Wolf M.
        • Hennerici M.G.
        Ischemic stroke in young adults: classification and risk factors.
        J Neurol. 2012; 259: 653-659
        • Feigin V.L.
        • Forouzanfar M.H.
        • Krishnamurthi R.
        • Mensah G.A.
        • Connor M.
        • Bennett D.A.
        • et al.
        Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010) and the GBD Stroke Experts Group. Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010.
        Lancet. 2013; 383: 245-254
        • Bejot Y.
        • Daubail B.
        • Jacquin A.
        • Durier J.
        • Osseby G.V.
        • Rouaud O.
        • et al.
        Trends in the incidence of ischaemic stroke in young adults between 1985 and 2011: the Dijon Stroke Registry.
        J Neurol Neurosurg Psychiatry. Nov 18 2013; https://doi.org/10.1136/jnnp-2013-306203
        • Mohan H.
        • Sood G.
        Conjugate deviation of the eyes after Cannabis indica intoxication.
        Br J Ophthalmol. 1964; 48: 160-161
        • Garett C.
        • Braithwaite R.A.
        • Teale J.D.
        Unusual case of tetrahydrocannabinol intoxication confirmed by radioimmunoassay.
        Br J Med. 1977; 2: 166
        • Cooles P.
        • Michaud R.
        Stroke after heavy marijuana smoking.
        Post Grad Med J. 1987; 63: 511
        • Zacchariah S.B.
        Stroke after heavy marijuana smoking.
        Stroke. 1991; 22: 406-409
        • Barnes D.
        • Palace J.
        • O'Brien M.D.
        Stroke following marijuana smoke.
        Stroke. 1992; 23: 1381
        • McCarron M.
        • Thomas A.M.
        Cannabis and alcohol in stroke.
        Postgrad Med J. 1997; 73: 448
        • Mesec A.
        • Rot U.
        • Grad A.
        Cerebrovascular disease associated with marijuana abuse: a case report.
        Cerebrovasc Dis. 2001; 11: 284-285
        • Marinella M.A.
        Stroke after marijuana smoking in a teenager with factor V Leiden mutation.
        South Med J. 2001; 94: 1217-1218
        • Alvaro L.C.
        • Iriondo I.
        • Villaverde F.J.
        Sexual headache and stroke in a heavy cannabis smoker.
        Headache. 2002; 48: 178-180
        • Russmann S.
        • Winkler A.
        • Lovblad K.O.
        • Stanga Z.
        • Basetti C.
        Lethal ischemic stroke after cisplatin-based chemotherapy for testicular carcinoma and cannabis inhalation.
        Eur Neurol. 2002; 48: 178-180
        • Finsterer J.
        • Christian P.
        • Wolfgang K.
        Occipital stroke shortly after cannabis consumption.
        Clin Neurol Neurosurg. 2004; 106: 305-308
        • Geller T.
        • Loftis L.
        • Brink D.
        Cerebellar infarction in adolescent males associated with acute marijuana use.
        Pediatrics. 2004; 113: e365-e370
        • Haubrich C.
        • Diehl R.
        • Dönges M.
        • Sciefer J.
        • Loos M.
        • Kosinski C.
        Recurrent transient ischemic attacks in a cannabis smoker.
        J Neurol. 2005; 252: 369-370
        • Mateo I.
        • Pindo A.
        • Gomez-Beldarrain M.
        • Basterretxea J.M.
        • Garcia-Monco J.C.
        Recurrent stroke associated with cannabis use.
        J Neurol Neurosurg Psychiatry. 2005; 76: 435-437
        • Mateo I.
        • Infante J.
        • Gomez-Beldarrain M.
        • Garcia-Monco J.C.
        Cannabis and cerebrovascular disease.
        Neurologia. 2006; 21: 204-208
        • Termote B.
        • Verswijvel G.
        • Palmers Y.
        Cannabis-induced brain ischemia.
        JBR-BTR. 2007; 90: 218-219
        • Calabrese L.H.
        • Dodick D.W.
        • Schwedt T.J.
        • Singhal A.B.
        Narrative review: reversible cerebral vasoconstriction syndromes.
        Ann Intern Med. 2007; 146: 34-44
        • Koopman K.
        • Teune L.K.
        • ter Laan M.
        • Uyittenboogaart M.
        • Vroomen P.C.
        • De Keyser J.
        • et al.
        An often unrecognized cause of thunderclap headache: reversible cerebral vasoconstriction syndrome.
        J Headache Pain. 2008; 9: 389-391
        • Renard D.
        • Taieb G.
        • Gras-Combe G.
        • Labauge P.
        Cannabis-related myocardial infarction and cardioembolic stroke.
        J Stroke Cerebrovasc Dis. 2012; 21: 82-83
        • Bal S.
        • Khurana D.
        • Lal V.
        • Prabhakar S.
        Posterior circulation stroke in a cannabis abuser.
        Neurol India. 2009; 57: 91-92
        • Duchene C.
        • Olindo S.
        • Chausson N.
        • Jeannin S.
        • Cohen-Tenoutji Smadja D.
        Cannabis-induced cerebral and myocardial infarction in a young woman.
        Rev Neurol. 2010; 166: 438-442
        • Leblanc A.
        • Tirel-Badets A.
        • Paleiron N.
        • Castellant P.
        • Cornily J.C.
        • Andre M.
        • et al.
        Cannabis et infarctus du myocarde du sujet jeune: association fortuite? A propos d'une observation.
        Ann Cardiol Angeiol. 2011; 60: 154-158
        • Trojak B.
        • Leclerq S.
        • Meille V.
        • Khoumri C.
        • Chauvet-Gelinier J.-C.
        • Giroud M.
        • et al.
        Stroke with neuropsychiatric sequelae after cannabis use in a man: a case report.
        J Med Case Rep. 2011; 5: 264
        • Maguire M.
        • Seidi O.
        • Baker M.
        • Gupta A.
        • Muwanga C.
        Acute mutism: a useful lesson.
        Emerg Med J. 2011; 28: 82-83
        • Singh N.N.
        • Pan Y.
        • Muengtaweeponsa S.
        • Geller T.J.
        • Cruz-Flores S.
        Cannabis-related stroke: case series and review of literature.
        J Stroke Cerebrovasc Dis. 2012; 21: 555-560
        • Barbieux M.
        • Veran O.
        • Detante O.
        Accidents vasculaires cérébraux ischémiques du sujet jeune et toxiques.
        Rev Med Interne. 2012; 33: 35-40
        • Lawson T.M.
        • Rees A.
        Stroke and transient ischaemic attacks in association with substance abuse in a young man.
        Postgrad Med J. 1996; 72: 692-693
        • Mouzak A.
        • Agathos P.
        • Kerezoudi E.
        • Mantas A.
        • Vourdeli-Yiannakoura E.
        Transient ischemic attack in heavy cannabis smokers-how “safe” is it?.
        Eur Neurol. 2000; 44: 42
        • Renard D.
        • Gaillard N.
        Brain haemorrhage and cerebral vasospasm associated with chronic use of cannabis and buprenorphine.
        Cerebrovasc Dis. 2008; 25: 282-283
        • Whitlock J.B.
        • Robinson G.T.
        • Whitlock J.P.
        • Dredla B.K.
        • Barrett K.M.
        Mystery case: a 21-year-old man with visual loss following marijuana use.
        Neurology. 2015; 84: E165-E169
        • Yau W.Y.
        • Chu E.
        • Lai N.
        Cannabis, serotonergic drug use and stroke in a 50-year-old woman.
        Intern Med J. 2015; 45: 1312-1313
        • Ntlholang O.
        • McDonagh R.
        • Nicholson S.
        • Brett F.
        • Bradley D.
        • Harbison J.
        Is intimal hyperplasia associated with cranial arterial stenosis in cannabis-associated cerebral infarction?.
        Int J Stroke. 2015; 10: E56-E59
        • Domi R.
        • Janko A.
        • Sula H.
        An unusual postoperative cerebral ischemic stroke.
        J Anesth. 2015; 29: 157
        • Tsivgoulis G.
        • Lachanis S.
        • Papathanasiou M.A.
        • Chondrogianni M.
        • Brountzos E.N.
        • Voumvourakis K.
        Cannabis-associated angiopathy: an uncommon cause of crescendo transient ischemic attacks.
        Circulation. 2014; 30: 2069-2070
        • Santos A.F.
        • Rodrigues M.
        • Mare R.
        • Ferreira C.
        • Soares-Fernandes J.
        • Rocha J.
        Recurrent stroke in a young cannabis user.
        J Neuropsychiatr Clin Neurosci. 2014; 26: E41-E42
        • Oyinloye O.
        • Nzeh D.
        • Yusuf A.
        • Sanya E.
        Ischemic stroke following abuse of marijuana in a Nigerian adult male.
        J Neurosci Rural Pract. 2014; 5: 417-419
        • Nouh A.
        • Ruland S.
        • Schneck M.J.
        • Pasquale D.
        • Biller J.
        Reversible cerebral vasoconstriction syndrome with multivessel cervical artery dissections and a double aortic arch.
        J Stroke Cerebrovasc Dis. 2014; 23: E141-E143
        • Ibrir M.
        • Ouadahi N.
        • Hamzaoui N.
        • Zemmour D.
        • Ghita D.H.
        • Habouchi A.
        • et al.
        Peripheral arteritis disease and ischemic strokes in cannabis use: a case report.
        Thromb Res. 2014; 133: S115-S116
        • Baharnoori M.
        • Kassardjian C.D.
        • Saposnik G.
        Cannabis use associated with capsular warning syndrome and ischemic stroke.
        Can J Neurol Sci. 2014; 41: 272-273
        • Inal T.
        • Kose A.
        • Koksal O.
        • Armagan E.
        • Aydin S.A.
        • Ozdemir F.
        Acute temporal lobe infarction in a young patient associated with marijuana abuse: an unusual cause of stroke.
        World J Emerg Med. 2014; 5: 72-74
        • El Scheich T.
        • Weber A.-A.
        • Klee D.
        • Schweiger D.
        • Mayatepek E.
        • Karenfort M.
        Adolescent ischemic stroke associated with anabolic steroid and cannabis abuse.
        J Pediatr Endocrinol Metab. 2013; 26: 161-165
        • Ince B.
        • Benbir G.
        • Yuksel O.
        • Koseoglu L.
        • Uluduz D.
        Both hemorrhagic and ischemic stroke following high doses of cannabis consumption.
        Presse Med. 2015; 44: 106-107
        • Marder C.P.
        • Donohue M.M.
        • Weinstein J.R.
        • Fink K.R.
        Multimodal imaging of reversible cerebral vasoconstriction syndrome: a series of 6 cases.
        Am J Neuroradiol. 2012; 33: 1403-1410
        • Noskin O.
        • Jafarimojarrad E.
        • Libman R.B.
        • Nelson J.L.
        Diffuse cerebral vasoconstriction (call-Fleming syndrome) and stroke associated with antidepressants.
        Neurology. 2006; 67: 159-160
        • Robert T.
        • Marchini A.K.
        • Oumarou G.
        • Uske A.
        Reversible cerebral vasoconstriction syndrome identification of prognostic factors.
        Clin Neurol Neurosurg. 2013; 115: 2351-2357
        • Wolff V.
        • Armspach J.P.
        • Lauer V.
        • Rouyer O.
        • Ducros A.
        • Marescaux C.
        • et al.
        Ischaemic strokes with reversible vasoconstriction and without thunderclap headache: a variant of the reversible cerebral vasoconstriction syndrome?.
        Cerebrovasc Dis. 2015; 39: 31-38
        • Jamil M.
        • Zafar A.
        • Adeel Faizi S.
        • Zawar I.
        Stroke from vasospasm due to marijuana use: can cannabis synergistically with other medications trigger cerebral vasospasm?.
        Case Rep Neurol Med. 2016; 2016 ([Epub 2016 Oct 19]): 5313795
        • Tirkey N.K.
        • Gupta S.
        Acute antero-inferior wall ischaemia with acute ischaemic stroke caused by oral ingestion of cannabis in a young male.
        J Assoc Physicians India. 2016; 64: 93-94
        • Desbois A.C.
        • Cacoub P.
        Cannabis-associated aterial disease.
        Ann Vasc Surg. 2013; 27: 996-1005
        • Hackam D.G.
        Cannabis and stroke: a systematic appraisal of case reports.
        Stroke. 2015; 46: 852-856
        • Caldigott D.G.E.
        • Holmes J.
        • Roberts-Thomson K.C.
        • Mahar L.
        Keep of the grass: marijuana use and acute cardiovascular events.
        Eur J Emerg Med. 2005; 12: 236-244
        • Thanvi B.R.
        • Treadwell S.D.
        Cannabis and stroke: is there a link?.
        Postgrad Med J. 2009; 85: 80-83
        • Moussouttas M.
        Cannabis use and cerebrovascular disease.
        Neurologist. 2004; 10: 47-53
        • Singhal A.B.
        • Hajj-Ali R.A.
        • Topcuoglu M.A.
        • Fok J.
        • Bena J.
        • Yang D.
        • et al.
        Reversible cerebral vasoconstriction syndromes: analysis of 139 cases.
        Arch Neurol. 2011; 68: 1005-1012
        • Jouanjus E.
        • Leymarie F.
        • Tubery M.
        • Lapeyre-Mestre M.
        Cannabis-related hospitalizations: unexpected serious events identified through hospital databases.
        Br J Clin Pharmacol. 2011; 71: 758-765
        • Barber P.A.
        • Pridmore H.M.
        • Krishnamurthy V.
        • Roberts S.
        • Spriggs D.A.
        • Carter K.N.
        • et al.
        Cannabis, ischemic stroke, and transient ischemic attack a case–control study.
        Stroke. 2013; 44: 2327-2329
        • Jouanjus E.
        • Lapeyre-Mestre M.
        • Micallef J.
        Cannabis use: signal of increasing risk of serious cardiovascular disorders.
        J Am Heart Assoc. 2014; 3e000638
        • Hemachandra D.
        • McKetin R.
        • Cherbuin N.
        • Anstey K.J.
        Heavy cannabis users at elevated risk of stroke: evidence from a general population survey.
        Aust N Z J Public Health. 2016; 40: 226-230
        • Rumalla K.
        • Reddy A.Y.
        • Mittal M.K.
        Recreational marijuana use and acute ischemic stroke: a population based analysis of hospitalized patients in the United States.
        J Neurol Sci. 2016; 364: 191-196
        • Rumalla K.
        • Reddy A.Y.
        • Mittal M.K.
        Association of recreational marijuana use with aneurysmal subarachnoid hemorrhage.
        J Stroke Cerebrovasc Dis. 2016; 25: 452-460
        • Di Napoli M.
        • Zha A.M.
        • Godoy D.A.
        • Masotti L.
        • Schreuder F.H.B.M.
        • Popa-Wagner A.
        • et al.
        Cerebrovasc Dis. 2016; 41: 248-255
        • Behrouz R.
        • Birnbaum L.
        • Grandhi R.
        • Johnson J.
        • Misra V.
        • Palacio S.
        • et al.
        Cannabis use and outcomes in patients with aneurysmal subarachnoid hemorrhage.
        Stroke. 2016; 47: 1371-1373
        • Kamat A.S.
        • Aliashkevich A.F.
        • Denton J.R.
        • Fitzjohn T.P.
        Headache after substance abuse: a diagnostic dilemma.
        J Clin Neurosci. 2012; 19: 464-466
        • Ray W.Z.
        • Krisht K.M.
        • Schabel A.
        • Schmidt R.H.
        Subarachnoid hemorrhage from a thoracic radicular artery pseudoaneurysm after methamphetamine and synthetic cannabinoid abuse: case report.
        Global Spine J. 2013; 3: 119-124
        • Sherpa D.
        • Paudel B.M.
        • Subedi B.H.
        • Chow R.D.
        Synthetic cannabinoids: the multi-organ failure and metabolic derangements associated with getting high.
        J Community Hosp Intern Med Perspect. 2015; 5: 27540
        • Bernson-Leung M.E.
        • Leung L.Y.
        • Kumar S.
        Synthetic cannabis and acute ischemic stroke.
        J Stroke Cerebrovasc Dis. 2014; 23: 1239-1241
        • Freeman M.J.
        • Rose D.Z.
        • Myers M.A.
        • Gooch C.L.
        • Bozeman A.C.
        • Burgin W.S.
        Ischemic stroke after use of the synthetic marijuana “spice”.
        Neurology. 2013; 81: 2090-2093
        • Takematsu M.
        • Hoffman R.S.
        • Nelson L.S.
        • Schechter J.M.
        • Moran J.H.
        • Wiener S.W.
        A case of acute cerebral ischemia following inhalation of a synthetic cannabinoid.
        Clin Toxicol. 2014; 52: 973-975
        • Rose D.Z.
        • Guerrero W.R.
        • Mokin M.V.
        • Gooch C.L.
        • Bozeman A.C.
        • Pearson J.M.
        • et al.
        Hemorrhagic stroke following use of the synthetic marijuana “spice”.
        Neurology. 2015; 85: 1177-1179
        • Degirmenci Y.
        • Kececi H.
        • Olmez N.
        A case of ischemic stroke after bonzai: syntetic cannabinoid from Turkey.
        Neurol Sci. 2016; 37: 299-300
        • Keskin M.
        • Hayıroğlu M.İ.
        • Keskin Ü.
        • Eren M.
        Acute myocardial infarction and ischemic stroke coexistence due to marijuana abuse in an adolescent.
        Anatol J Cardiol. 2016; 16: 542-543
        • Raheemullah A.
        • Laurence T.N.
        Repeated thrombosis after synthetic cannabinoid use.
        J Emerg Med. 2016; 51: 540-543
        • Hirapara K.
        • Aggarwal R.
        Synthetic cannabis use and stroke: a rising risk?.
        Int J Stroke. Oct 2016; 11 ([Epub 2016 Mar 23]): NP78https://doi.org/10.1177/1747493016641956
        • Wolff V.
        • Lauer V.
        • Rouyer O.
        • Sellal F.
        • Meyer N.
        • Raul J.S.
        • et al.
        Cannabis use, ischemic stroke, and multifocal intracranial vasoconstriction: a prospective study in 48 consecutive young patients.
        Stroke. 2011; 42: 1778-1780
        • Ducros A.
        Reversible cerebral vasoconstriction syndrome.
        Lancet Neurol. 2012; 11: 906-917
        • Wolff V.
        • Ducros A.
        Reversible cerebral vasoconstriction syndrome without typical thunderclap headache.
        Headache. 2016; 56: 674-677
        • Le Boisselier R.
        • Alexandre J.
        • Lelong-Boulouard V.
        • Debruyne D.
        Focus on cannabinoids and synthetic cannabinoids.
        Clin Pharmacol Ther. Nov 9 2016; ([Epub ahead of print])https://doi.org/10.1002/cpt.563
        • Wolff V.
        • Schlagowski A.I.
        • Rouyer O.
        • Charles A.L.
        • Singh F.
        • Auger C.
        • et al.
        Tetrahydrocannabinol (THC) induces brain mitochondrial respiratory chain dysfunction and increases oxidative stress: a potential mechanism involved in cannabis-related stroke.
        Biomed Res Int. 2015; 2015 ([Epub 2015 Jan 14]): 323706https://doi.org/10.1155/2015/323706
        • Chen H.
        • Yoshioka H.
        • Kim G.S.
        • Jung J.E.
        • Okami N.
        • Sakata H.
        • et al.
        Oxidative stress in ischemic brain damage: mechanisms of cell death and potential molecular targets for neuroprotection.
        Antioxid Redox Signal. 2011; 14: 1505-1517
        • Wolff V.
        • Rouyer O.
        • Geny B.
        Stroke related to marijuana: an underestimated risk.
        N Engl J Med. 2014; 371 ([Letter]): 878
        • Deplanque D.
        Recreational cannabis use: not so harmless!.
        J Neurol Neurosurg Psychiatry. 2005; 76: 306
        • Johnson L.D.
        • O'Malley P.M.
        • Bachman J.G.
        • Schelenberg J.E.
        Monitoring the future: national results on adolescent drug use-overview of key findings.
        the University of Michigan Institute for Social Research, Ann Arbor2011
        • Ducros A.
        • Boukobza M.
        • Porcher R.
        • Sarov M.
        • Valade D.
        • Bousser M.G.
        The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients.
        Brain. 2007; 130: 3091-3101
        • Chen S.P.
        • Fuh J.L.
        • Wang S.J.
        • Chang F.C.
        • Lirng J.F.
        • Fang Y.C.
        • et al.
        Magnetic resonance angiography in reversible cerebral vasoconstriction syndromes.
        Ann Neurol. 2010; 67: 648-656
        • Katz B.S.
        • Fugate J.E.
        • Ameriso S.F.
        • Pujol-Lereis V.A.
        • Mandrekar J.
        • Flemming K.D.
        • et al.
        Clinical worsening in reversible cerebral vasoconstriction syndrome.
        JAMA Neurol. 2014; 71: 68-73
        • Thomas G.
        • Kloner R.A.
        • Reskalla S.
        Adverse cardiovascular, cerebrovascular, and peripheral vascular effects of marijuana inhalation: what cardiologists need to know?.
        Am J Cardiol. 2014; 113: 187-190
      4. Prevalence of Intracranial Arterial Stenosis in Regular Resin of Cannabis Users Compared to Control Subjects: a Preliminary Study of Feasibility. ClinicalTrials.gov identifier: NCT02246140. https://clinicaltrials.gov/ct2/show/NCT02246140